drugset / Trial / NCT03310060
Reducing Blood Loss Using Tisseel in TKA
RandomizedSingle-groupSingle-blindPrevention
Summary
The purpose of this study is to conduct a prospective randomized controlled trial to investigate the blood-conservation effect of the topical hemostatic agents in patients receiving primary TKA procedures. The investigators will also observe if there is increased risk of blood transfusion rate by using topical hemostatic agents or not.
Timeline
- Start
- 2017-11-01
- Primary completion
- 2018-08-31
- Completion
- 2018-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Fibrinogen Concentrate Human | Protein / enzyme biologic | 4 ml | Topical |
| Comparator | Tranexamic Acid | Small molecule | 15 mg/kg | Intravenous |
Indications
No indication recorded.